Evidence map›Paper›PMID 37353830›Full record

ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2023

Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study.

Paul K Keith, Juthaporn Cowan, Amin Kanani, Harold Kim, Gina Lacuesta, Jason K Lee, Jie Chen, Michelle Park, André Gladiator

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Infusion parameters, safety, and practical guidance for the manual administration of subcutaneous immunoglobulin 20% (Ig20Gly).Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Paul K KeithDivision of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada.
Juthaporn CowanDivision of Infectious Diseases, Department of Medicine, Department of Biochemistry, Microbiology, and Immunology; Centre for Infection, Immunity and Inflammation, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, K1H 8M5, Canada.
Amin KananiDivision of Allergy and Clinical Immunology, Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, BC, V6Z 1Y6, Canada.
Harold KimDivision of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON, L8N 3Z5, Canada.
Gina LacuestaDepartment of Medicine, Dalhousie University, Halifax, NS, B3H 2Y9, Canada.
Jason K LeeChair of Toronto Allergists and Evidence Based Medical Educator, Toronto, ON, M5G 1E2, Canada.
Jie ChenTakeda Development Center Americas, Inc., Cambridge, MA, 02139, USA.
Michelle ParkTakeda Development Center Americas, Inc., Cambridge, MA, 02139, USA.
André GladiatorGlattpark‑Opfikon, Takeda Pharmaceuticals International AG, Thurgauerstrasse 130, 8152, Zurich, Switzerland. andre.gladiator@takeda.com.ORCID http://orcid.org/0000-0002-9025-5626
Takeda (United States) · USDalhousie University · CAMcMaster University · CATakeda (Switzerland) · CHUniversity of British Columbia · CAUniversity of Ottawa · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37353830
PMCPMC10290310
OpenAlexW4381838902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.